Jan. 13, 2009-Taisho Pharmaceutical Co., Ltd. has reached an agreement with Glaxo Group Limited, a subsidiary of GlaxoSmithKline plc to grant Taisho the rights for the development and marketing of the anti-obesity drug orlistat, in Japan.
The details can be read here.
No comments:
Post a Comment